Each film coated tablet contains Febuxostat INN 40mg
It is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of Allopurinol, who are intolerant to Allopurinol, or for whom treatment with Allopurinol is not advisable. It is not recommended for the treatment of asymptomatic hyperuricemia.
Each film coated tablet contains Febuxostat INN 40mg
It is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of Allopurinol, who are intolerant to Allopurinol, or for whom treatment with Allopurinol is not advisable. It is not recommended for the treatment of asymptomatic hyperuricemia.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.